Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Kyowa Kirin Announces Discontinuation of Rocatinlimab Clinical Trials
-
Xunlei Limited Announces Entry into Definitive Agreements for Disposition of Majority Equity Interest in Shenzhen Onething
-
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share
-
Antelope Enterprise Holdings Limited Announce Reverse Split Record Date
-
KUSTOM ENTERTAINMENT’S DIGITAL ALLY BRAND SECURES MULTI-YEAR BODY CAMERA SUBSCRIPTION WITH PREMIER KANSAS CITY BASED HEALTH SYSTEM
-
Kognitos Bridges the AI Trust Gap with Governed, Deterministic Execution for the Autonomous Enterprise
-
FactSet Integrates Advanced AI Financial Crime Risk Management Tools into Workstation for Corporate Banks
-
Aptera Motors Completes First Vehicle off Validation Assembly Line
-
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
-
Village Super Market, Inc. Reports Results for the Second Quarter Ended January 24, 2026
-
ICBA Securities Selects The Baker Group as New Endorsed Provider Following Comprehensive Review
-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended December 31, 2025 and Declaration of Distributions on Common Stock for the Months Ending Apri
-
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
-
Cross Keys Capital Advises SEPA Pain & Spine in Its Partnership with DxTx Pain & Spine
-
National Healthcare Properties Announces $64 million SHOP Acquisition
-
64% of Women Developers Say AI Has Increased Their Career Agency, BairesDev’s Survey Finds
-
Perceptyx Acquires Lyceum AI to Close the Gap Between Employee Experience and Learning and Development
-
Sironix Renewables Launches Furasoft™ – Next Generation, Bio-Based Surfactant for Personal Care
-
Byrna Technologies Announces CEO Transition
-
YETI Holdings, Inc. Announces Participation in Upcoming Investor Conferences
-
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference
-
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
-
Abundia Global Impact Group to Participate in Water Tower Research Fireside Chat on Wednesday, March 4, 2026
-
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
-
Upexi to Participate in Upcoming March Investor Conferences
-
PEDEVCO Announces 1-For-20 Reverse Stock Split
-
Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis
-
Discuss Introduces Real-Time AI Translation for Observers, Making Global Research Truly Universal
-
Comscore to Announce Fourth Quarter and Full Year 2025 Financial Results
-
Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast
-
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
-
Kratos Receives $7 Million Order for Counter-UAS Systems
-
Smart Buildings: Leveraging Sustainable AI to Reduce Carbon and Costs
-
Medidata’s Experience-based AI Earns Top Luminary Rating in Everest Group 2026 Review
-
Dateline Commences Music Valley Exploration Program
-
United States Antimony Corporation Announces Completion of Technical Report located in Ontario, Canada on Fostung Tungsten Deposit
-
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
-
Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief
-
BK Technologies to Participate at the 38th Annual ROTH Conference
-
Babson Diagnostics Names Web Golinkin CEO
-
Click Media, a GameSquare Company, Wins Influencer Management Agency of the Year
-
T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors
-
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
-
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
-
Elektros Inc. Secures U.S. Patent from the U.S. Patent and Trademark Office for Innovative Multi-Port Electric Vehicle Charging Technology
-
OMP Unveils Decision-Centric Planning to Accelerate Supply Chain Decision Velocity
-
Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
-
Headwall Partners Announces Publication - "Headwall 2026 Steel & Metals Outlook Survey"
-
Gaudenzia Strengthens Integrated Treatment Model, Driving the Next Era of Recovery Care
-
Visual Edge IT Appoints Peter Stelling as Chief Operating Officer
